GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.
Based on Q1 2026 filing
Provides a comprehensive suite of scanning technologies and AI-enabled software to visualize anatomical structures and functional processes. These solutions support clinical specialties including oncology, cardiology, and neurology.
Molecular Imaging (MI), Computed Tomography (CT), Magnetic Resonance (MR), PET/CT, PET/MR, SPECT, Women’s Health X-ray, Fixed room radiography
Hospitals, Imaging centers, Academic institutions, Public and private health systems
Focuses on specialized ultrasound and procedural guidance technologies designed for specific clinical workflows. This segment supports diagnostic, interventional, and surgical settings with real-time imaging and AI-guided instructions.
Comprehensive Care Ultrasound, Women’s Health Ultrasound, CardioVascular and Interventional Solutions, Surgical Innovations mobile C-arms, AI-guided ultrasound software
Surgical centers, Cardiology clinics, Obstetrics and gynecology practices, Operating rooms
Delivers monitoring and life support systems that aggregate clinical data in real time to support clinical decision-making. The segment includes a significant portfolio of recurring revenue through consumables and digital service subscriptions.
Patient Monitoring systems, Diagnostic Cardiology (ECG/EKG), Maternal Infant Care (incubators, warmers), Anesthesia delivery systems, Clinical consumables, Digital Solutions decision support software
Labor and delivery departments, Neonatal intensive care units, Ambulatory surgical centers, Hospitals
Develops and supplies contrast media and radiopharmaceuticals used in medical imaging to enhance the visibility of tissues and assess cell function. This segment operates a sophisticated global supply chain for time-sensitive molecular tracers.
Contrast media, Radiopharmaceuticals, Molecular tracers, Contrast injection devices
Radiology departments, Nuclear medicine clinics, Pharmaceutical companies, Research institutions
A leading global provider with a 130-year history and a massive installed base of connected devices across 160 countries.
Global, United States, Europe, Emerging Markets
Hospitals, Health systems, Government institutions, Academic researchers
Radioisotope suppliers, Electronic component manufacturers, Raw material suppliers for contrast media, Software developers
Public hospitals, Private health systems, Diagnostic laboratories, Clinical research organizations
Medtronic
MDT
Danaher
DHR
Stryker
SYK
Boston Scientific
BSX
Agilent Technologies
A
Abbott
ABT
Cardinal Health
CAH
IQVIA
IQV
Teledyne Technologies
TDY
Johnson & Johnson
JNJ
Cognizant
CTSH
Intuitive Surgical
ISRG
Roper Technologies, Inc.
ROP
Quest Diagnostics
DGX
HEICO
HEI
Labcorp Holdings
LH
STERIS
STE
West Pharmaceutical Services
WST
ResMed
RMD
Common questions about GE HealthCare Technologies
GE HealthCare is a global medical technology and pharmaceutical diagnostics company that provides advanced medical devices, imaging agents, and digital health solutions. The company focuses on delivering precision care through a combination of hardware, AI-enabled software, and clinical services to help clinicians diagnose and treat complex diseases. Its value proposition centers on integrating diagnostic tools with data-driven insights to improve patient outcomes and operational efficiency for healthcare providers.
GE HealthCare Technologies (GEHC) has a market capitalization of $28.0B and trades on NASDAQ.
GE HealthCare Technologies generated $21.0B in trailing twelve-month revenue with net income of $1.9B, representing a net margin of 9.1%. Gross margin stands at 39.1%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.
GE HealthCare Technologies's key competitors include Medtronic plc, Philips Healthcare, Danaher Corporation, and others. These companies compete in similar markets and product categories.
GE HealthCare Technologies has approximately 51,000 employees.